FDA.reportPublic FDA data

METRONIDAZOLE

Substance profile for UNII 140QMO216E, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for METRONIDAZOLE
Structure render from PubChem CID 4173

Substance Identity#

UNII
140QMO216E
Preferred term
METRONIDAZOLE
Registry number
443-48-1
EC number
207-136-1
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
C6H9N3O3
Chemical structure for METRONIDAZOLE
Structure render from PubChem CID 4173

Chemical And Database Identifiers#

InChIKey
VAOCPAMSLUNLGC-UHFFFAOYSA-N
SMILES
CC1=NC=C(N1CCO)[N+]([O-])=O
RxCUI
6922
PubChem
4173
NCIt
C651
INN ID
1032

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
PubChem Compound4173pubchem.ncbi.nlm.nih.gov/compound/4173
PubChem InChIKey SearchVAOCPAMSLUNLGC-UHFFFAOYSA-Npubchem.ncbi.nlm.nih.gov/#query=VAOCPAMSLUNLGC-UHFFFAOYSA-N
RxNorm6922mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=6922
NCI ThesaurusC651ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C651
FDA Substance Registration System140QMO216Eprecision.fda.gov/uniisearch/srs/unii/140QMO216E
European Community number207-136-1commonchemistry.cas.org/results?q=207-136-1

DailyMed Socrata Ingredients#

Type, DailyMed label, SPL version table
TypeDailyMed labelSPL version
ACTIVE MOIETYMetronidazole Gel USP, 0.75%1
ACTIVE INGREDIENTMetronidazole Gel USP, 0.75%1
ACTIVE MOIETYMETRONIDAZOLE TABLETS, USP 250 mg and 500 mg Revised: August 2014 Rx only3
ACTIVE INGREDIENTMETRONIDAZOLE TABLETS, USP 250 mg and 500 mg Revised: August 2014 Rx only3
ACTIVE INGREDIENTMETRONIDAZOLE TABLETS USP1
ACTIVE MOIETYMETRONIDAZOLE TABLETS USP1
ACTIVE INGREDIENTMetronidazole2
ACTIVE MOIETYMetronidazole2
ACTIVE MOIETYMETRONIDAZOLE TABLETS, USP 250 mg and 500 mg Revised: August 2014 Rx only1
ACTIVE INGREDIENTMETRONIDAZOLE TABLETS, USP 250 mg and 500 mg Revised: August 2014 Rx only1
ACTIVE INGREDIENTMetronidazole1
ACTIVE MOIETYMetronidazole1
ACTIVE INGREDIENTThese highlights do not include all the information needed to use METRONIDAZOLE GEL, 1% safely and effectively. See full prescribing information for METRONIDAZOLE GEL, 1%. METRONIDAZOLE GEL, 1% For topical use. Initial U.S. Approval: 19631
ACTIVE MOIETYThese highlights do not include all the information needed to use METRONIDAZOLE GEL, 1% safely and effectively. See full prescribing information for METRONIDAZOLE GEL, 1%. METRONIDAZOLE GEL, 1% For topical use. Initial U.S. Approval: 19631
ACTIVE MOIETYMETRONIDAZOLE TABLETS USP 500 mg Rx only6
ACTIVE INGREDIENTMETRONIDAZOLE TABLETS USP 500 mg Rx only6
ACTIVE INGREDIENTMETRONIDAZOLE TABLETS USP5
ACTIVE MOIETYMETRONIDAZOLE TABLETS USP5
ACTIVE INGREDIENTMETRONIDAZOLE TABLETS USP2
ACTIVE MOIETYMETRONIDAZOLE TABLETS USP2
ACTIVE MOIETYMetronidazole Vaginal Gel, 0.75%1
ACTIVE INGREDIENTMetronidazole Vaginal Gel, 0.75%1
ACTIVE MOIETYMETRONIDAZOLE TABLETS USP 250 mg AND 500 mg Revised: April 2013 Rx only1
ACTIVE INGREDIENTMETRONIDAZOLE TABLETS USP 250 mg AND 500 mg Revised: April 2013 Rx only1
ACTIVE INGREDIENTMETRONIDAZOLE TABLETS USP1
ACTIVE MOIETYMETRONIDAZOLE TABLETS USP1
ACTIVE INGREDIENTfb79c214-e6ff-499a-9e23-a759bef9b7cb2
ACTIVE MOIETYfb79c214-e6ff-499a-9e23-a759bef9b7cb2
ACTIVE INGREDIENTRev. A 6/2011 Rx only To reduce the development of drug-resistant bacteria and maintain the effectiveness of metronidazole and other antibacterial drugs, metronidazole should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.7
ACTIVE MOIETYRev. A 6/2011 Rx only To reduce the development of drug-resistant bacteria and maintain the effectiveness of metronidazole and other antibacterial drugs, metronidazole should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.7
ACTIVE MOIETYROSACLEAR ® SYSTEM1
ACTIVE INGREDIENTROSACLEAR ® SYSTEM1
ACTIVE MOIETYMETRONIDAZOLE TABLETS USP2
ACTIVE INGREDIENTMETRONIDAZOLE TABLETS USP2
ACTIVE MOIETYMETRONIDAZOLE TABLETS USP1
ACTIVE INGREDIENTMETRONIDAZOLE TABLETS USP1
ACTIVE INGREDIENTMetronidazole Vaginal Gel, 0.75%1
ACTIVE MOIETYMetronidazole Vaginal Gel, 0.75%1
ACTIVE INGREDIENTThese highlights do not include all the information needed to use METROGEL (metronidazole) Gel, 1% safely and effectively. See full prescribing information for METROGEL (metronidazole) Gel, 1% METROGEL® (metronidazole) Gel, 1% For topical use only. Initial U.S. Approval 19632
ACTIVE MOIETYThese highlights do not include all the information needed to use METROGEL (metronidazole) Gel, 1% safely and effectively. See full prescribing information for METROGEL (metronidazole) Gel, 1% METROGEL® (metronidazole) Gel, 1% For topical use only. Initial U.S. Approval 19632
ACTIVE INGREDIENTMetronidazole Topical Gel USP, 0.75%1
ACTIVE MOIETYMetronidazole Topical Gel USP, 0.75%1
ACTIVE INGREDIENTMetronidazole Tablets2
ACTIVE MOIETYMetronidazole Tablets2
ACTIVE MOIETYMETRONIDAZOLE TABLETS USP1
ACTIVE INGREDIENTMETRONIDAZOLE TABLETS USP1
ACTIVE MOIETY1787c491-d92c-4239-9d9f-6a91b629835d1
ACTIVE INGREDIENT1787c491-d92c-4239-9d9f-6a91b629835d1
ACTIVE INGREDIENTbd3b62b6-4a80-495b-a1d3-d54eb15baf791
ACTIVE MOIETYbd3b62b6-4a80-495b-a1d3-d54eb15baf791
ACTIVE INGREDIENTThese highlights do not include all the information needed to use PYLERA safely and effectively. See full prescribing information for PYLERA. Initial U.S. Approval: 20061
ACTIVE MOIETYThese highlights do not include all the information needed to use PYLERA safely and effectively. See full prescribing information for PYLERA. Initial U.S. Approval: 20061
ACTIVE INGREDIENTMETRONIDAZOLE TABLETS USP4
ACTIVE MOIETYMETRONIDAZOLE TABLETS USP4
ACTIVE MOIETY818dbe07-0267-4682-b171-5ab022ef98011
ACTIVE INGREDIENT818dbe07-0267-4682-b171-5ab022ef98011
ACTIVE INGREDIENTMETRONIDAZOLE TABLETS USP, 250 mg and 500 mg1
ACTIVE MOIETYMETRONIDAZOLE TABLETS USP, 250 mg and 500 mg1
ACTIVE MOIETYMetronidazole Injection2
ACTIVE INGREDIENTMetronidazole Injection2
ACTIVE INGREDIENTMETRONIDAZOLE TABLETS, USP1
ACTIVE MOIETYMETRONIDAZOLE TABLETS, USP1
ACTIVE MOIETYMETRONIDAZOLE Topical Cream 0.75%2
ACTIVE INGREDIENTMETRONIDAZOLE Topical Cream 0.75%2
ACTIVE MOIETYMETRONIDAZOLE TOPICAL LOTION, 0.75%2
ACTIVE INGREDIENTMETRONIDAZOLE TOPICAL LOTION, 0.75%2
ACTIVE MOIETYMetronidazole Cream, 1%5
ACTIVE INGREDIENTMetronidazole Cream, 1%5
ACTIVE INGREDIENTMetronidazole Tablets USP Revised: July 2004 Rx only3
ACTIVE MOIETYMetronidazole Tablets USP Revised: July 2004 Rx only3
ACTIVE MOIETYMetronidazole Tablets USP Rx only1
ACTIVE INGREDIENTMetronidazole Tablets USP Rx only1
ACTIVE MOIETYMETRONIDAZOLE TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3875
ACTIVE INGREDIENTMETRONIDAZOLE TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3875
ACTIVE INGREDIENTMETRONIDAZOLE TABLET [REMEDYREPACK INC. ]86
ACTIVE MOIETYMETRONIDAZOLE TABLET [REMEDYREPACK INC. ]86
ACTIVE INGREDIENTMETRONIDAZOLE TABLET [REMEDYREPACK INC. ]70
ACTIVE MOIETYMETRONIDAZOLE TABLET [REMEDYREPACK INC. ]70
ACTIVE INGREDIENTMETRONIDAZOLE TABLET [REMEDYREPACK INC. ]69
ACTIVE MOIETYMETRONIDAZOLE TABLET [REMEDYREPACK INC. ]69
ACTIVE MOIETYMETRONIDAZOLE TABLET [REMEDYREPACK INC. ]46
ACTIVE INGREDIENTMETRONIDAZOLE TABLET [REMEDYREPACK INC. ]46
ACTIVE INGREDIENTMETRONIDAZOLE INJECTION, SOLUTION [HOSPIRA, INC.]14
ACTIVE MOIETYMETRONIDAZOLE INJECTION, SOLUTION [HOSPIRA, INC.]14
ACTIVE INGREDIENTMETRONIDAZOLE CAPSULE [HERITAGE PHARMACEUTICALS INC.]11
ACTIVE MOIETYMETRONIDAZOLE CAPSULE [HERITAGE PHARMACEUTICALS INC.]11
ACTIVE MOIETYMETRONIDAZOLE INJECTION, SOLUTION [CLARIS LIFESCIENCES INC.]11
ACTIVE INGREDIENTMETRONIDAZOLE INJECTION, SOLUTION [CLARIS LIFESCIENCES INC.]11
ACTIVE INGREDIENTMETRONIDAZOLE TABLET [ACTAVIS PHARMA, INC.]11
ACTIVE MOIETYMETRONIDAZOLE TABLET [ACTAVIS PHARMA, INC.]11
ACTIVE INGREDIENTFLAGYL (METRONIDAZOLE) TABLET, FILM COATED [G.D. SEARLE LLC DIVISION OF PFIZER INC]10
ACTIVE MOIETYFLAGYL (METRONIDAZOLE) TABLET, FILM COATED [G.D. SEARLE LLC DIVISION OF PFIZER INC]10
ACTIVE MOIETYPYLERA (BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE, TETRACYCLINE HYDROCHLORIDE) CAPSULE [APTALIS PHARMA US, INC.]10
ACTIVE INGREDIENTPYLERA (BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE, TETRACYCLINE HYDROCHLORIDE) CAPSULE [APTALIS PHARMA US, INC.]10
ACTIVE MOIETYFLAGYL (METRONIDAZOLE) CAPSULE [G.D. SEARLE LLC DIVISION OF PFIZER INC]9
ACTIVE INGREDIENTFLAGYL (METRONIDAZOLE) CAPSULE [G.D. SEARLE LLC DIVISION OF PFIZER INC]9
ACTIVE MOIETYMETRONIDAZOLE SOLUTION [B. BRAUN MEDICAL INC.]9
ACTIVE INGREDIENTMETRONIDAZOLE SOLUTION [B. BRAUN MEDICAL INC.]9
ACTIVE MOIETYMETRONIDAZOLE INJECTION, SOLUTION [BAXTER HEALTHCARE CORPORATION]8
ACTIVE INGREDIENTMETRONIDAZOLE INJECTION, SOLUTION [BAXTER HEALTHCARE CORPORATION]8
ACTIVE INGREDIENTMETRONIDAZOLE TABLET [PD-RX PHARMACEUTICALS, INC.]7
ACTIVE MOIETYMETRONIDAZOLE TABLET [PD-RX PHARMACEUTICALS, INC.]7
ACTIVE MOIETYMETRONIDAZOLE TABLET [REMEDYREPACK INC. ]7
ACTIVE INGREDIENTMETRONIDAZOLE TABLET [REMEDYREPACK INC. ]7
ACTIVE MOIETYMETRONIDAZOLE (METRONIDAZOLE) TABLET [PD-RX PHARMACEUTICALS, INC.]6
ACTIVE INGREDIENTMETRONIDAZOLE (METRONIDAZOLE) TABLET [PD-RX PHARMACEUTICALS, INC.]6
ACTIVE MOIETYMETRONIDAZOLE GEL [E. FOUGERA & CO. A DIVISION OF FOUGERA PHARMACEUTICALS INC.]6
ACTIVE INGREDIENTMETRONIDAZOLE GEL [E. FOUGERA & CO. A DIVISION OF FOUGERA PHARMACEUTICALS INC.]6
ACTIVE MOIETYMETRONIDAZOLE TABLET [CARDINAL HEALTH]6
ACTIVE INGREDIENTMETRONIDAZOLE TABLET [CARDINAL HEALTH]6
ACTIVE MOIETYMETRONIDAZOLE TABLET [PD-RX PHARMACEUTICALS, INC.]6
ACTIVE INGREDIENTMETRONIDAZOLE TABLET [PD-RX PHARMACEUTICALS, INC.]6
ACTIVE MOIETYMETROGEL (METRONIDAZOLE) GEL [GALDERMA LABORATORIES, L.P.]5
ACTIVE INGREDIENTMETROGEL (METRONIDAZOLE) GEL [GALDERMA LABORATORIES, L.P.]5
ACTIVE INGREDIENTMETRONIDAZOLE GEL [SANDOZ INC.]5
ACTIVE MOIETYMETRONIDAZOLE GEL [SANDOZ INC.]5
ACTIVE INGREDIENTMETRONIDAZOLE LOTION [E. FOUGERA & CO. A DIVISION OF FOUGERA PHARMACEUTICALS INC.]5
ACTIVE MOIETYMETRONIDAZOLE LOTION [E. FOUGERA & CO. A DIVISION OF FOUGERA PHARMACEUTICALS INC.]5
ACTIVE INGREDIENTMETRONIDAZOLE TABLET [APPCO PHARMACEUTICALS CORP]5
ACTIVE MOIETYMETRONIDAZOLE TABLET [APPCO PHARMACEUTICALS CORP]5